Shuntvitien

Nach Korrektur eines Shuntvitiums sind vor allem pulmonalhypertensive Krisen mit dem Risiko der akuten Rechtsherzdekompensation problematisch. Die intensivmedizinische Therapie zielt auf eine pulmonale Nachlastsenkung und Unterstützung des rechten Ventrikels.

• Literatur

• 1 Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 2010; 222: 321-326
• 2 Weil J. Deutsche Gesellschaft für Pädiatrische Kardiologie e. V.. Leitlinien zur Diagnostik und Therapie in der Pädiatrischen Kardiologie. München: Urban & Fischer; 2016
• 3 Klauwer D, Neuhäuser C, Thul J, Zimmermann R. et al. Pädiatrische Intensivmedizin – Kinderkardiologische Praxis. Köln: Deutscher Ärzte-Verlag; 2013
• 4 van Riel AC, Blok IM, Zwinderman AH. et al. Lifetime risk of pulmonary hypertension for all patients after shunt closure. J Am Coll Cardiol 2015; 66: 1084-1086
• 5 Chen TH, Hsiao YC, Cheng CC. et al. In-Hospital and 4-Year Clinical Outcomes Following Transcatheter Versus Surgical Closure for Secundum Atrial Septal Defect in Adults: A National Cohort Propensity Score Analysis. Medicine (Baltimore) 2015; 94: e1524
• 6 Takaya Y, Akagi T, Kijima Y. et al. Long-term outcome after transcatheter closure of atrial septal defect in older patients: impact of age at procedure. JACC Cardiovasc Interv 2015; 8: 600-606
• 7 Schubert S, Peters B, Abdul-Khaliq H. et al. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv 2005; 64: 333-337
• 8 Abman SH, Hansmann G, Archer SL. et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation 2015; 132: 2037-2099
• 9 Galiè N, Humbert M, Vachiery JL. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67-119
• 10 Zhang HD, Zhang R, Jiang X. et al. Effects of oral treatments on clinical outcomes in pulmonary arterial hypertension: A systematic review and meta-analysis. Am Heart J 2015; 170: 96-103
• 11 Blok IM, Van Riel AC, Mulder BJ. et al. Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions. Expert Rev Cardiovasc Ther 2015; 13: 1377-1392
• 12 Manes A, Palazzini M, Leci E. et al. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J 2014; 35: 716-724
• 13 Egbe AC, Poterucha JT, Rihal CS. et al. Transcatheter closure of postmyocardial infarction, iatrogenic, and postoperative ventricular septal defects: The Mayo Clinic experience. Catheter Cardiovasc Interv 2015; 86: 1264-1270
• 14 Thiele H, Kaulfersch C, Daehnert I. et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J 2009; 30: 81-88